Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model
Objective The Type 1 and 2 systemic lupus erythematosus (SLE) Model was developed to encapsulate all signs and symptoms that patients with SLE experience. Our previous qualitative work demonstrated the model accurately reflects the lived experience of people living with SLE. The objective of this st...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | ACR Open Rheumatology |
| Online Access: | https://doi.org/10.1002/acr2.11748 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850108741701074944 |
|---|---|
| author | Amanda M. Eudy Megan E. B. Clowse Amy Corneli Summer Starling Nneka Jebose Molokwu Teresa Swezey David S. Pisetsky Mithu Maheswaranathan Jayanth Doss Kai Sun Rebecca E. Sadun Lisa G. Criscione‐Schreiber Jennifer L. Rogers |
| author_facet | Amanda M. Eudy Megan E. B. Clowse Amy Corneli Summer Starling Nneka Jebose Molokwu Teresa Swezey David S. Pisetsky Mithu Maheswaranathan Jayanth Doss Kai Sun Rebecca E. Sadun Lisa G. Criscione‐Schreiber Jennifer L. Rogers |
| author_sort | Amanda M. Eudy |
| collection | DOAJ |
| description | Objective The Type 1 and 2 systemic lupus erythematosus (SLE) Model was developed to encapsulate all signs and symptoms that patients with SLE experience. Our previous qualitative work demonstrated the model accurately reflects the lived experience of people living with SLE. The objective of this study was to present the Type 1 and 2 SLE Model to rheumatologists to understand how the model fits with their experiences treating patients with SLE. Methods We conducted a qualitative descriptive study using semistructured interviews with rheumatologists. Rheumatologists were asked about their general impression of the Type 1 and 2 SLE Model, how the model does or does not fit within their approach to treating patients with SLE, the utility of the model in clinical practice, and any suggested changes. Applied thematic analysis identified salient themes. Results We interviewed 13 rheumatologists. The majority of rheumatologists approved of the model and found it useful to guide therapy and clinical decision‐making. Several rheumatologists thought the model was helpful for patient education to manage expectations about differences between Type 1 and Type 2 symptoms and treatments. A few rheumatologists expressed concern that the model could lead to an overdiagnosis of SLE. Conclusion The Type 1 and 2 SLE Model was accepted by most rheumatologists interviewed and welcomed as a useful approach to identifying and treating symptoms in patients with SLE. Future studies will determine how implementing the Type 1 and 2 SLE Model affects patient understanding, the physician–patient relationship, and clinical outcomes. |
| format | Article |
| id | doaj-art-7ad26ea092184ebc8203f86102546348 |
| institution | OA Journals |
| issn | 2578-5745 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | ACR Open Rheumatology |
| spelling | doaj-art-7ad26ea092184ebc8203f861025463482025-08-20T02:38:17ZengWileyACR Open Rheumatology2578-57452024-12-0161286587010.1002/acr2.11748Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus ModelAmanda M. Eudy0Megan E. B. Clowse1Amy Corneli2Summer Starling3Nneka Jebose Molokwu4Teresa Swezey5David S. Pisetsky6Mithu Maheswaranathan7Jayanth Doss8Kai Sun9Rebecca E. Sadun10Lisa G. Criscione‐Schreiber11Jennifer L. Rogers12Duke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine and Durham Veterans Affairs Medical Center Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaDuke University School of Medicine Durham North CarolinaObjective The Type 1 and 2 systemic lupus erythematosus (SLE) Model was developed to encapsulate all signs and symptoms that patients with SLE experience. Our previous qualitative work demonstrated the model accurately reflects the lived experience of people living with SLE. The objective of this study was to present the Type 1 and 2 SLE Model to rheumatologists to understand how the model fits with their experiences treating patients with SLE. Methods We conducted a qualitative descriptive study using semistructured interviews with rheumatologists. Rheumatologists were asked about their general impression of the Type 1 and 2 SLE Model, how the model does or does not fit within their approach to treating patients with SLE, the utility of the model in clinical practice, and any suggested changes. Applied thematic analysis identified salient themes. Results We interviewed 13 rheumatologists. The majority of rheumatologists approved of the model and found it useful to guide therapy and clinical decision‐making. Several rheumatologists thought the model was helpful for patient education to manage expectations about differences between Type 1 and Type 2 symptoms and treatments. A few rheumatologists expressed concern that the model could lead to an overdiagnosis of SLE. Conclusion The Type 1 and 2 SLE Model was accepted by most rheumatologists interviewed and welcomed as a useful approach to identifying and treating symptoms in patients with SLE. Future studies will determine how implementing the Type 1 and 2 SLE Model affects patient understanding, the physician–patient relationship, and clinical outcomes.https://doi.org/10.1002/acr2.11748 |
| spellingShingle | Amanda M. Eudy Megan E. B. Clowse Amy Corneli Summer Starling Nneka Jebose Molokwu Teresa Swezey David S. Pisetsky Mithu Maheswaranathan Jayanth Doss Kai Sun Rebecca E. Sadun Lisa G. Criscione‐Schreiber Jennifer L. Rogers Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model ACR Open Rheumatology |
| title | Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model |
| title_full | Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model |
| title_fullStr | Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model |
| title_full_unstemmed | Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model |
| title_short | Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model |
| title_sort | perspectives of rheumatologists on the type 1 and 2 systemic lupus erythematosus model |
| url | https://doi.org/10.1002/acr2.11748 |
| work_keys_str_mv | AT amandameudy perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT meganebclowse perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT amycorneli perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT summerstarling perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT nnekajebosemolokwu perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT teresaswezey perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT davidspisetsky perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT mithumaheswaranathan perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT jayanthdoss perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT kaisun perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT rebeccaesadun perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT lisagcriscioneschreiber perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel AT jenniferlrogers perspectivesofrheumatologistsonthetype1and2systemiclupuserythematosusmodel |